Maxcyte (MXCT) EBITDA (2020 - 2026)
Maxcyte (MXCT) posted quarterly EBITDA of -$6.2 million for Q1 2026, up 49.69% year-over-year from -$4.1 million in Q1 2025, and up 44.9% quarter-over-quarter from -$11.2 million in Q4 2025.
Maxcyte (MXCT) EBITDA (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported EBITDA for 7 consecutive years, with -$6.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA rose 49.69% year-over-year to -$6.2 million; the TTM figure through Mar 2026 stood at -$45.8 million (up 10.6% YoY), while the FY2025 annual figure was -$51.9 million, down 1.37% from the prior year.
- EBITDA climbed to -$6.2 million in Q1 2026 per MXCT's latest filing, from -$11.2 million in the prior quarter.
- Across five years, EBITDA topped out at -$4.2 million in Q1 2022 and bottomed at -$14.2 million in Q2 2025.
- Historically, EBITDA has averaged -$10.9 million across 5 years, with a median of -$12.3 million in 2024.
- Annual changes were most pronounced in 2023 — EBITDA slumped 216.85% — and 2026, when it soared 49.69%.
- Maxcyte's EBITDA stood at -$6.8 million in 2022, then retreated by 19.93% to -$8.1 million in 2023, then plunged by 59.35% to -$12.9 million in 2024, then gained by 12.98% to -$11.2 million in 2025, then soared by 44.9% to -$6.2 million in 2026.
- Business Quant data shows MXCT's EBITDA at -$6.2 million in Q1 2026, -$11.2 million in Q4 2025, and -$14.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Maxcyte | 147.42 Mn | 147.42 Mn | 5.60 Mn | -9.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.23 Mn |
| Mar 31, 2026 | -6.19 Mn |
| Dec 31, 2025 | -11.23 Mn |
| Sep 30, 2025 | -14.15 Mn |
| Jun 30, 2025 | -14.23 Mn |
| Mar 31, 2025 | -12.30 Mn |
| Dec 31, 2024 | -12.90 Mn |
| Sep 30, 2024 | -14.05 Mn |
| Jun 30, 2024 | -11.97 Mn |
| Mar 31, 2024 | -12.28 Mn |
| Dec 31, 2023 | -8.10 Mn |
| Sep 30, 2023 | -13.95 Mn |
| Jun 30, 2023 | -13.07 Mn |
| Mar 31, 2023 | -13.18 Mn |
| Dec 31, 2022 | -6.75 Mn |
| Sep 30, 2022 | -7.71 Mn |
| Jun 30, 2022 | -8.74 Mn |
| Mar 31, 2022 | -4.16 Mn |
| Dec 31, 2021 | -4.96 Mn |
| Sep 30, 2021 | -2.44 Mn |